Skip to content

Exercise in Patients With Osteoarthritis of the Hip

Effects of Strength Training and Nordic Walking in Patients With Osteoarthritis of the Hip

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01387867
Enrollment
152
Registered
2011-07-06
Start date
2009-10-31
Completion date
2014-01-31
Last updated
2015-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis

Keywords

Exercise, Hip osteoarthritis, Randomized controlled trial

Brief summary

According to Danish and international guidelines the recommended first-line of management for people with osteoarthritis consist of exercise, education, analgesic medication, and, if necessary, weight reduction. It is well documented that exercise has a positive effect on pain and physical function in patients with knee OA, but the effect of exercise on hip OA is sparsely investigated. Aim of the study: To investigate the effects of 1) strength training, and 2) Nordic Walking, and 3) unsupervised home based exercise on muscle function, endurance, pain level, physical activity, and health related quality of life in patients with osteoarthritis of the hip. The effects of exercise on muscle mass and the mechanisms behind the osteoarthritis, i.e., disease activity, inflammation, and cartilage degradation, are investigated in a subgroup (n=45) of the participants. Study hypotheses: Strength training will have a greater effect on physical function and muscle strength than Nordic Walking and home based exercise; 2) Nordic Walking will have a greater effect on endurance than strength training and unsupervised home based exercise; 3) Strength training and Nordic Walking will have a greater effect on pain level and health related quality of life than unsupervised home based exercise.

Interventions

PROCEDUREStrength training

Supervised strength training in groups 2 x 1 hour weekly and un-supervised strength training 1 hour weekly for 4 months

Supervised Nordic Walking in groups 2 x 1 hour weekly and un-supervised Nordic Walking 1 hour weekly for 4 months

PROCEDUREUnsupervised home based exercise

Unsupervised home based exercise as recommended by the Danish Arthritis Association 1 hour 3 x weekly for 4 months

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1)Home-dwelling 60+ year old persons with primary, symptomatic hip OA who meet the clinical criteria of hip OA according to American College of Rheumatology (ACR), and who are not on a waiting list for hip joint replacement.

Exclusion criteria

1. symptomatic OA in the knee or the big toe, 2. joint replacement of the knee or the hip, 3. other types of arthritis, e.g., rheumatoid arthritis, 4. previous hip fracture, 5. limitation in physical function to the extent that using public transportation is impossible, 6. co-morbidity that prevents exercising, 7. physiotherapy related to hip problems within the last 3 months, 8. steroid injections in the hip joint within the last 3 months, 9. performing exercise/sports 2+ times weekly, and 10. inability to cooperate.

Design outcomes

Primary

MeasureTime frame
Change from Baseline to 2, 4 and 12 months in number of chair stands in 30 sec at 2, 4 and 12 monthsBaseline, 2, 4 and 12 months

Secondary

MeasureTime frameDescription
Change from Baseline to 2, 4 and 12 months in 6 minute walking distance (m), stair climbing time (s), 15 s marching on the spot (number of knee lifts), Timed-Up-and-Go (s) at 2, 4 and 12 monthsBaseline, 2, 4, and 12 months
Change from Baseline to 4 months in biomarkers of disease activity, inflammation, and cartilage degradation, in a subgroup (15 participants from each group)Baseline and 4 monthsBlood samples: COMP (cartilage oligomeric matrix protein) and CRP (C-reactive protein)and Urine sample: CTX II (C-terminal telopeptide of collagen II)
Change in task specific self-efficacy from baseline to 2, 4 and 12 monthsBaseline, 2, 4 and 12 monthsSelf-efficacy in relation to stair climbing performance.
Change in patient global assessment from baseline to 2, 4 and 12 months.Baseline to 2, 4 and 12 months
Change from Baseline in self-reported physical activity at 2, 4 and 12 monthsBaseline, 2, 4, and 12 monthsPASE (Physical Activity Scale for the Elderly) and a question from Copenhagen City Heart Study
Change from Baseline in health related quality of life at 2, 4 and 12 monthsBaseline, 2, 4, and 12 monthsSF-36
Change from Baseline to 2, 4 and 12 months in isometric muscle strength (N) of the thigh and hip muscles at 2, 4 and 12 monthsBaseline, 2, 4, and 12 months
Change from Baseline to 2, 4 and 12 months in lower limb extensor muscle power (Watt/kg BW) at 2, 4 and 12 monthsBaseline, 2, 4, and 12 months
Change from Baseline in self-reported pain level at 2, 4 and 12 monthsBaseline, 2, 4, and 12 monthsHOOS (Hip dysfunction and Osteoarthritis Outcome Score) and VAS (Visual Analogue scale)
Change from Baseline to 4 months in the anatomical cross sectional area (cm2) of the quadriceps femoris muscle measured with MRI. The measurements are performed in a subgroup (15 participants from each group)Baseline and 4 monthsMRI (magnetic resonance imaging)- The anatomical cross sectional area is measured at mid-thigh level, i.e. 20 cm proximal to the tibia plateau.

Other

MeasureTime frameDescription
Change in perceived competence from baseline to 4 and 12 monthsBaseline, 4 and 12 monthsPerceived Competence Scale
Change in illness perception from baseline to 12 monthsBaseline and 12 monthsBrief Illness Perception Questionnaire
Change in arthritis-specific self-efficacy from baseline to 4 and 12 monthsBaseline, 4 and 12 monthsArthritis-specific Self-efficacy Scale

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026